Neurocrine Biosciences
NBIX
NBIX
133 hedge funds and large institutions have $1.68B invested in Neurocrine Biosciences in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 46 reducing their positions, and 22 closing their positions.
Holders
133
Holders Change
–
Holders Change %
0%
% of All Funds
3.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
25
Increased
44
Reduced
46
Closed
22
Calls
$17.4M
Puts
$52.4M
Net Calls
-$35.1M
Net Calls Change
-$37.4M
Top Buyers
| 1 |
1
Jennison Associates
New York
|
$19.7M |
| 2 |
2
Millennium Management
New York
|
$27.3M |
| 3 |
PC
3
PointState Capital
New York
|
$16.8M |
| 4 |
VAM
4
Visium Asset Management
New York
|
$55M |
| 5 |
CCI
5
Columbus Circle Investors
|
$12.6M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
QT
151
Quantbot Technologies
New York
| – | -$70K | -4,469 | Closed |
|
|
PCM
152
Prelude Capital Management
New York
| – | -$39K | -2,500 | Closed |
|
|
PTC
153
Private Trust Company
Cleveland,
Ohio
| – | -$10K | -631 | Closed |
|
|
NFG
154
Next Financial Group
Houston,
Texas
| – | -$7K | -430 | Closed |
|
155
Ameriprise
Minneapolis,
Minnesota
| – | -$6K | -385 | Closed |
|
156
Envestnet Asset Management
Chicago,
Illinois
| – | -$1K | -35 | Closed |
|